Tag

Christopher Viehbacher

1 article

Braveheart Bio IPO Shares Jump 68%

Braveheart Bio debuted on Nasdaq Global Market (ticker BRVE) at $30.20, surging 68% above the $18 IPO price. The $382.5 million IPO valued the company at $2.13 billion, with $185 million secured from